Skip to content

Study on the guiding role of laparoscopic indocyanine green fluorescence imaging in lymph node resection of endometrial cancer

Study on the guiding role of laparoscopic indocyanine green fluorescence imaging in lymph node resection of endometrial cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046388
Enrollment
Unknown
Registered
2021-05-15
Start date
2021-05-09
Completion date
Unknown
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Sponsors

Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. First diagnosis and initial treatment; 2. Comply with the diagnosis of endometrial cancer, the size of the uterus is less than or equal to 8 weeks of pregnancy, who can undergo laparoscopic surgery; 3. Aged 18-69 years; 4. The patient voluntarily signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of allergy to iodine-containing contrast media; 2. Patients who have surgical contraindications and/or cannot accept laparoscopic surgery; 3. Patients with severe internal or surgical diseases, severe pelvic adhesions; 4. Patients with other malignant tumors.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Secondary

MeasureTime frame
Lymph node metastasis rate;

Countries

China

Contacts

Public ContactMiao Jinwei

Beijing Obstetrics and Gynecology Hospital, Capital Medical University

miaojinweigyn@163.com+86 1851805638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026